Skip to Content
Merck
CN
  • Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.

Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.

Nature communications (2019-11-27)
Erica McGrath, Hyunsu Shin, Linyi Zhang, Je-Nie Phue, Wells W Wu, Rong-Fong Shen, Yoon-Young Jang, Javier Revollo, Zhaohui Ye
ABSTRACT

DNA base editors have enabled genome editing without generating DNA double strand breaks. The applications of this technology have been reported in a variety of animal and plant systems, however, their editing specificity in human stem cells has not been studied by unbiased genome-wide analysis. Here we investigate the fidelity of cytidine deaminase-mediated base editing in human induced pluripotent stem cells (iPSCs) by whole genome sequencing after sustained or transient base editor expression. While base-edited iPSC clones without significant off-target modifications are identified, this study also reveals the potential of APOBEC-based base editors in inducing unintended point mutations outside of likely in silico-predicted CRISPR-Cas9 off-targets. The majority of the off-target mutations are C:G->T:A transitions or C:G->G:C transversions enriched for the APOBEC mutagenesis signature. These results demonstrate that cytosine base editor-mediated editing may result in unintended genetic modifications with distinct patterns from that of the conventional CRISPR-Cas nucleases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Oct-4 Antibody, clone 10H11.2, clone 10H11.2, Chemicon®, from mouse
Sigma-Aldrich
Anti-TRA-1-60 Antibody, clone TRA-1-60, clone TRA-1-60, Chemicon®, from mouse